HAIFA, Israel, Sept. 6, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based ...
Click here to read more Please take some time to check out the adverts on the right hand side of this page thanks for your visits